Found: 14
Select item for more details and to access through your institution.
New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 461, doi. 10.1007/s13300-020-00988-7
- By:
- Publication type:
- Article
Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 465, doi. 10.1007/s13300-020-00973-0
- By:
- Publication type:
- Article
A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 487, doi. 10.1007/s13300-020-00983-y
- By:
- Publication type:
- Article
Linear Projection of Estimated Glomerular Filtration Rate Decline with Canagliflozin and Implications for Dialysis Utilization and Cost in Diabetic Nephropathy.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 499, doi. 10.1007/s13300-020-00953-4
- By:
- Publication type:
- Article
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 509, doi. 10.1007/s13300-020-00982-z
- By:
- Publication type:
- Article
Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 527, doi. 10.1007/s13300-020-00984-x
- By:
- Publication type:
- Article
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 537, doi. 10.1007/s13300-020-00989-6
- By:
- Publication type:
- Article
Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 557, doi. 10.1007/s13300-020-00992-x
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 569, doi. 10.1007/s13300-020-00987-8
- By:
- Publication type:
- Article
A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 581, doi. 10.1007/s13300-020-00993-w
- By:
- Publication type:
- Article
Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 595, doi. 10.1007/s13300-020-00995-8
- By:
- Publication type:
- Article
Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 2, p. 613, doi. 10.1007/s13300-020-00985-w
- By:
- Publication type:
- Article
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: The Effects of Mobile-App-Based Low-Carbohydrate Dietary Guidance on Postprandial Hyperglycemia in Adults with Prediabetes.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice